Bioleaders Corporation Cash Flow Reinvestment Rate

Latest as of September 2024: 76.60x

Bioleaders Corporation cash flow reinvestment rate. Bioleaders Corporation (142760) has a Cash Flow Reinvestment Rate of 76.60x as of September 2024, reinvesting ₩3.80 Billion (capex ₩1.04 Billion plus investments ₩2.75 Billion) from operating cash flow of ₩49.56 Million. Explore Bioleaders Corporation cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

76.60x

(Capex + Investments) / Operating CF

Total Reinvested

₩3.80 Billion

Capex + Investments

Operating Cash Flow

₩49.56 Million

KRW

Capital Expenditures

₩1.04 Billion

KRW

Cash Flow Reinvestment Rate of Bioleaders Corporation (2023–2023)

Cash flow reinvestment rate of Bioleaders Corporation from 2023 to 2023. Historical reinvestment intensity for Bioleaders Corporation across 1 annual periods. Explore Bioleaders Corporation (142760) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.

Bioleaders Corporation Cash Flow Reinvestment Rate by Year (2023–2023)

Bioleaders Corporation cash flow reinvestment rate by year from 2023 to 2023. Year-by-year capital reinvestment analysis for Bioleaders Corporation. For the full cash flow conversion analysis, see Bioleaders Corporation (142760) cash flow conversion.

Year	Reinvestment Rate	Total Reinvested (KRW)	Operating CF	Capex	YoY Change
2023	5.01x	₩30.93 Billion	₩6.18 Billion	₩378.81 Million	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow